US7820634B2ExpiredUtilityA1

Composition and method for production of transformed cells

95
Assignee: PURDUE RESEARCH FOUNDATIONPriority: Feb 17, 1995Filed: May 2, 2007Granted: Oct 26, 2010
Est. expiryFeb 17, 2015(expired)· nominal 20-yr term from priority
Inventors:Stephen F. BadylakJeffrey BonadioSherry Voytik
A61K 48/00A61F 2002/30677A61L 27/3629A61F 2210/0004A61K 35/38A61F 2002/30062A61K 48/0025A61F 2/28A61F 2002/2835A61L 27/38
95
PatentIndex Score
17
Cited by
42
References
15
Claims

Abstract

A composition useful for the production of transformed eukaryotic cells is described. The composition comprises submucosal tissue and a nucleic acid sequence. The nucleic acid sequence is typically recombinant DNA including gene(s) encoding for one or more biofunctional proteins. The submucosal tissue component of the present composition comprises the tunica submucosa of vertebrate intestine delaminated from the tunica muscularis and at least the luminal portion of the tunica mucosa. Injection or implantation of the composition into a host induces the formation of transformed cells capable of expressing gene(s) encoded by the nucleic acid sequence.

Claims

exact text as granted — not AI-modified
1. A method for delivery of a deoxyribonucleic acid to cells of a host vertebrate species, said method comprising the step of contacting the cells in vivo with a composition comprising a collagenous matrix and an added exogenous deoxyribonucleic acid, wherein the collagenous matrix comprises submucosa tissue delaminated from both the tunica muscularis and at least the luminal portion of the tunica mucosa of warm-blooded vertebrate submucosa and wherein the deoxyribonucleic acid encodes a biofunctional protein. 
     
     
       2. The method of  claim 1 , wherein the step of contacting the cells comprises the step of implanting the composition into the host vertebrate species. 
     
     
       3. The method of  claim 1 , wherein the submucosa tissue is intestinal submucosa. 
     
     
       4. The method of  claim 1 , wherein the submucosa tissue is in an injectable form and the step of contacting the cells comprises the step of injecting the composition into the host vertebrate species. 
     
     
       5. The method of  claim 1 , wherein the collagenous matrix consists essentially of the tunica submucosa, and the basilar portion of the tunica mucosa of the intestine of a warm-blooded vertebrate. 
     
     
       6. The method of  claim 1 , wherein the collagenous matrix comprises a component selected from the group consisting of a collagen, a glycoprotein, a proteoglycan, and a glycosaminoglycan. 
     
     
       7. The method of  claim 1 , wherein the collagenous matrix is obtained from a source selected from the group consisting of porcine, bovine, and ovine species. 
     
     
       8. The method of  claim 5  wherein the basilar portion of the tunica mucosa comprises the lamina muscularis mucosa and the stratum compactum. 
     
     
       9. The method of  claim 1  wherein the collagenous matrix is obtained from a pig. 
     
     
       10. The method of  claim 1  wherein the collagenous matrix is derived from intestinal tissue. 
     
     
       11. The method of  claim 9  wherein the collagenous matrix is derived from intestinal tissue. 
     
     
       12. The method of  claim 1  wherein the deoxyribonucleic acid comprises a plasmid. 
     
     
       13. The method of  claim 1  wherein the deoxyribonucleic acid is a recombinant deoxyribonucleic acid. 
     
     
       14. The method of  claim 1  wherein the submucosa tissue is in the form of a sheet. 
     
     
       15. The method of  claim 1  wherein the submucosa tissue is in the form of strips.

Join the waitlist — get patent alerts

Track US7820634B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.